High dose chemotherapy with stem cell rescue for breast cancer: Current status and future directionsELIAS, Anthony D.Breast disease. 2001, Vol 14, pp 51-68, issn 0888-6008Article

Lung cancer and chronic obstructive pulmonary diseasePETTY, T. L.Hematology/oncology clinics of North America. 1997, Vol 11, Num 3, issn 0889-8588, vii,531-541 [12 p.]Article

Prognostic markers in resectable non-small cell lung cancerSTRAUSS, G. M.Hematology/oncology clinics of North America. 1997, Vol 11, Num 3, pp v-vi, issn 0889-8588, 28 p.Article

Preoperative and postoperative care of standard and high risk surgical patientsREILLY, J. J.Hematology/oncology clinics of North America. 1997, Vol 11, Num 3, issn 0889-8588, vi,449-459 [12 p.]Article

Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer : Southwest oncology group/intergroup study 9623MOORE, Halle C. F; GREEN, Stephanie J; ELIAS, Anthony D et al.Journal of clinical oncology. 2007, Vol 25, Num 13, pp 1677-1682, issn 0732-183X, 6 p.Article

Phase II Study of Sunitinib Malate, an Oral Multitargeted Tyrosine Kinase Inhibitor, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a TaxaneBURSTEIN, Harold J; ELIAS, Anthony D; BAUM, Charles M et al.Journal of clinical oncology. 2008, Vol 26, Num 11, pp 1810-1816, issn 0732-183X, 7 p.Article

Phase II Study of Sorafenib in Patients With Metastatic or Recurrent SarcomasMAKI, Robert G; D'ADAMO, David R; TAKIMOTO, Chris H et al.Journal of clinical oncology. 2009, Vol 27, Num 19, pp 3133-3140, issn 0732-183X, 8 p.Article

Estrogen regulated gene expression in response to neoadjuvant endocrine therapy of breast cancers : tamoxifen agonist effects dominate in the presence of an aromatase inhibitorHARVELL, Djuana M. E; RICHER, Jennifer K; SINGH, Meenakshi et al.Breast cancer research and treatment. 2008, Vol 112, Num 3, pp 489-501, issn 0167-6806, 13 p.Article

Differences in Clinical Trial Patient Attributes and Outcomes According to Enrollment SettingLAMONT, Elizabeth B; LANDRUM, Mary Beth; MILLER, Antonius A et al.Journal of clinical oncology. 2010, Vol 28, Num 2, pp 215-221, issn 0732-183X, 7 p.Article

Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patientsRAMASWAMY, Bhuvaneswari; ELIAS, Anthony D; ECKHARDT, S. Gail et al.Clinical cancer research. 2006, Vol 12, Num 10, pp 3124-3129, issn 1078-0432, 6 p.Article